-
SBI Healthcare Opportunities Fund Regular Growth
Equity healthcare
Overview ( as on 20/12/24 )
NAV
₹425.34
Last change
₹-3.87 -0.01%
Fund Size (AUM)
3459.68 Cr
Performance
29.28% (5Y)
Fund Details
SBI Healthcare Opportunities Fund Regular Growth
as of 20/12/24
AUM
3459.68 Cr
Expense Ratio
1.95 %
Benchmark
BSE Healthcare TR INR
ISIN
INF200K01446
Fund Manager
Tanmaya Desai
Exit Load
0.5% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities Fund Regular Growth | 44.04% | 25.19% | 29.28% |
| BSE Healthcare TR INR | 43.76% | 19.63% | 26.27% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.87% |
Divi's Laboratories Ltd |
6.42% |
Cipla Ltd |
5.68% |
Max Healthcare Institute Ltd Ordinary Shares |
5.66% |
Lupin Ltd |
4.74% |
Poly Medicure Ltd |
4.02% |
Krishna Institute of Medical Sciences Ltd |
3.75% |
Jupiter Life Line Hospitals Ltd |
3.64% |
Aether Industries Ltd |
3.33% |
Ami Organics Ltd |
3.25% |
Sector Allocation
Healthcare |
93.18% |
Basic Materials |
6.82% |
Asset Allocation
-
97%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
30.29% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
29.28% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
29.28% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
27.43% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
30.74% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
27.39% (5Y)
-
